Structure via PubChem · Public domain (PubChem)
cosyntropin
Sign in to saveAlso known as SYN920, SYSMEHFRWGKPVGKKRRPVKVYP, Adrenocorticotropic hormone 1-24, SerTyrSerMetGluHisPheArgTrpGlyLysProValGlyLysLysArgArgProValLysValTyrPro, Corticotropin-(1-24) tetracosapeptide, Corticotropin-(1-24), beta(1-24)-Corticotrophin, alpha(1-24)-Corticotrophin
chemical compound
Chemical data
- Formula
- C136H210N40O31S
- Molecular weight
- 2933.4 g/mol
- IUPAC name
- (2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-amino-3-hydroxypropanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid
- SMILES
- CC(C)[C@@H](C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C(CO)N
- InChIKey
- ZOEFCCMDUURGSE-CQVUSSRSSA-N
- XLogP
- -7.9
- Polar surface area
- 1180 Ų
- H-bond donors
- 42
- H-bond acceptors
- 41
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Protein
- First approval
- 1970
- Admin. routes
- parenteral
- Indications
- membranous glomerulonephritis, hypertension, developmental and epileptic encephalopathy, adrenal gland disease
via ChEMBL · EBI
Research
2,206 papers- Adrenal venous sampling: cosyntropin stimulation or not?European journal of endocrinology · 2019
- Cosyntropin-Stimulated Aldosterone Reserve of the Nondominant Adrenal Predicts Surgical Outcomes in Primary Aldosteronism.Hypertension (Dallas, Tex. : 1979) · 2025
- Primary aldosteronism diagnosis: is cosyntropin stimulation in adrenal venous sampling still convincing?Journal of hypertension · 2021
- Heterogenous Responses to Cosyntropin in Primary Aldosteronism.The Journal of clinical endocrinology and metabolism · 2020
- Prophylactic cosyntropin after unintentional dural puncture and incidence of post-dural puncture headache and epidural blood patch use: A retrospective cohort study (2019-2022).International journal of obstetric anesthesia · 2024
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Part of
- corticotropin
- Mass
- 2931.5806409400057
- Has use
- medication
Show 6 more facts
- subject has role
- hormone
- canonical SMILES
- CC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)N
- chemical formula
- C₁₃₆H₂₁₀N₄₀O₃₁S
- World Health Organisation international non-proprietary name
- tetracosactide
- defined daily dose
- 0.25
- has characteristic
- biopharmaceutical
via Wikidata · CC0